ArticleBMC infectious diseases2025
Risk factors for dengue mortality: a 7-year retrospective cohort in Honduras.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Spatio-temporal forecasting of dengue in the Americas through hybrid mechanistic and data-driven models: Systematic review and meta-analysis.Infectious Disease Modelling · 2026Review
- Risk factors associated with dengue lethality: case-control study, Joinville, Brazil.Revista da Sociedade Brasileira de Medicina Tropical · 2026Article
- Dengue and severe dengue.Clinical microbiology reviews · 2025Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDengue is the viral disease with the highest morbidity and mortality rates worldwide. The aim of this study was to describe the epidemiological trends of dengue cases and dengue death cases and identify the demographic, clinical and laboratory risk factors for dengue mortality in Honduras.
methodsA retrospective cohort study of suspected cases of dengue between 2016 and 2022 was conducted. Patients of the 18 departments of the country were included. Patients were classified as deceased and alive. In the univariate analysis, normality test was assessed. In bivariate analysis, the chi-square and Mann Whitney U tests were used as appropriate. Crude odds ratios (cOR) with their respective 95% confidence intervals (CIs), were estimated to determine the risk of death due to dengue. In multivariate analysis, a logistic regression model was built.
resultsA total of 23,811 suspected cases of dengue were recorded, of which 14,927 tested positive, resulting in 242 deaths. The predominant sex among both deceased and surviving patients was female, 54.1% and 54.2%, respectively. Among the deceased, the largest age group was 5-9 years (32.6%), followed by 20-49 years (26.9%). Among surviving patients, the largest age groups were 20-49 years (28.9%) and 10-19 years (28.2%). Francisco Morazán reported the most dengue cases, while Cortés had the highest dengue deaths. Risk factors for dengue mortality included older age (> 60 years; adjusted OR 3.30, 95% CI 1.08-10.09), residence in the departments of Choluteca (aOR 19.40, 95% CI 4.75-79.30), Cortés (aOR 6.57, 95% CI 2.00-21.47), and Yoro (aOR 10.80, 95% CI 2.97-39.26), clinical manifestations of bleeding (aOR 1.81, 95% CI 1.09-3.00), clinical manifestations of plasma leakage (aOR 1.72, 95% CI 1.53-1.93), shock (aOR 10.70, 95% CI 7.90-14.50), lethargy (aOR 1.80, 95% CI 1.25-2.59), presence of comorbidities (aOR 1.89, 95% CI 1.08-3.29), and pregnancy (aOR 2.18, 95% CI 1.37-3.48).
conclusionOlder age; residence in the departments of Choluteca, Cortés, and Yoro; clinical manifestations of bleeding, plasma leakage, shock, lethargy; comorbidities and pregnancy were identified as risk factors for dengue mortality. Early identification of risk factors can help recognize patients who require close and timely clinical monitoring, which could improve outcomes in terms of reducing dengue mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.